From Neuron Imaging to Drug Discovery: Recursion and Genentech Advance Their First Neuroscience Target
A target identified through large-scale cell experiments and AI analysis has passed three stages of validation and entered small-molecule drug discovery. This marks a step forward for the collaboration, but the target’s identity and detailed data remain undisclosed, and demonstrating therapeutic efficacy is still a long way off.